Validation of a novel fluorescent lateral flow assay for rapid qualitative and quantitative assessment of total anti-sars-cov-2 s-rbd binding antibody units (bau) from plasma or fingerstick whole-blood of covid-19 vaccinees

HIGHLIGHTS

• who: Nadin Younes and colleagues from the Biomedical Research Center, University, New York, NY, USA have published the paper: Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees, in the Journal: Vaccines 2022, 1318 of /2022/
• future: The FinecareTM S-RBD Ab Test used be eradicated in the near future. Concordance assessment between FinecareTM and the three automated anti-SARS-CoV-2 Compared to Despite this rapidPositive progress . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.